These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19874927

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
    Blaney JE, Sathe NS, Hanson CT, Firestone CY, Murphy BR, Whitehead SS.
    Virol J; 2007 Feb 28; 4():23. PubMed ID: 17328799
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
    Blaney JE, Hanson CT, Hanley KA, Murphy BR, Whitehead SS.
    BMC Infect Dis; 2004 Oct 04; 4():39. PubMed ID: 15461822
    [Abstract] [Full Text] [Related]

  • 7. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy.
    Pletnev AG, Putnak R, Speicher J, Wagar EJ, Vaughn DW.
    Proc Natl Acad Sci U S A; 2002 Mar 05; 99(5):3036-41. PubMed ID: 11880643
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Genetically modified, live attenuated dengue virus type 3 vaccine candidates.
    Blaney JE, Hanson CT, Firestone CY, Hanley KA, Murphy BR, Whitehead SS.
    Am J Trop Med Hyg; 2004 Dec 05; 71(6):811-21. PubMed ID: 15642976
    [Abstract] [Full Text] [Related]

  • 11. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.
    Blaney JE, Johnson DH, Firestone CY, Hanson CT, Murphy BR, Whitehead SS.
    J Virol; 2001 Oct 05; 75(20):9731-40. PubMed ID: 11559806
    [Abstract] [Full Text] [Related]

  • 12. [Construction of infectious Japanese encephalitis virus clone based on the cDNA template of the attenuated live vaccine production strain SA14-14-2].
    Zeng M, Jia LL, Yu YX, Dong GM, Liu WX, Wang ZW, Li DF.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar 05; 19(1):9-11. PubMed ID: 16201461
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA.
    Butrapet S, Kinney RM, Huang CY.
    J Virol Methods; 2006 Jan 05; 131(1):1-9. PubMed ID: 16087248
    [Abstract] [Full Text] [Related]

  • 15. [Construction and identification of genomic cDNA subclones of dengue 2 virus NGC strain].
    Gong SJ, Cao H, Zhao W, Zhang WB, Zhou H, Chen LD.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr 05; 26(4):469-71. PubMed ID: 16624755
    [Abstract] [Full Text] [Related]

  • 16. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes.
    Connors M, Crowe JE, Firestone CY, Murphy BR, Collins PL.
    Virology; 1995 Apr 20; 208(2):478-84. PubMed ID: 7747420
    [Abstract] [Full Text] [Related]

  • 17. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F, Zhang Z, Myers G, Johnson BW, Pugachev K, Nichols R, Brown N, Levenbook I, Draper K, Cyrek S, Lang J, Fournier C, Barrere B, Delagrave S, Monath TP.
    J Virol; 2004 Sep 20; 78(18):9998-10008. PubMed ID: 15331733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.
    Mantel N, Girerd Y, Geny C, Bernard I, Pontvianne J, Lang J, Barban V.
    Vaccine; 2011 Sep 02; 29(38):6629-35. PubMed ID: 21745519
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates.
    Bernardo L, Izquierdo A, Alvarez M, Rosario D, Prado I, López C, Martínez R, Castro J, Santana E, Hermida L, Guillen G, Guzmán MG.
    Antiviral Res; 2008 Nov 02; 80(2):194-9. PubMed ID: 18602424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.